Literature DB >> 12372953

MPO-ANCA-associated small vessel vasculitis presenting as fever of unknown origin. Report of one case.

Harun Akar1, Cigdem Ozbasli-Levi, Taskin Senturk, Gurhan Kadikoylu, Edi Levi, Zahit Bolaman.   

Abstract

Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody (ANCA) associated small vessel vasculitis which can present with various clinical manifestations, for which the mainstay of treatment is systemic corticosteroids and immunosuppressants. We report a case of a 54-year-old female admitted to the hospital because of fever during the last month, leukocytosis and elevated erythrocyte sedimentation rate. Persistence of elevated serum creatinine levels and accompanying hematuria led us to perform a renal biopsy, and MPA was diagnosed on the basis of light and immunofluorescence microscopy. Remission was induced with oral corticosteroids and cyclophosphamide therapy in conjunction with plasmapheresis (PF). The objective of this report was to assess the role of PF in the treatment of MPA and report on its utility in patients with MPA who are not responding to standard therapy or who require unacceptably high doses of steroids or immunosuppressants. In a patient presenting with fever of unknown origin, microscopic polyangiitis should also be considered in the differential diagnosis. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372953     DOI: 10.1159/000064068

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Pyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis.

Authors:  O Shields; A Shah; B Mann
Journal:  BMJ Case Rep       Date:  2011-04-15

2.  Presence of neutrophil extracellular traps and antineutrophil cytoplasmic antibodies associated with vasculitides.

Authors:  Ana Maria Abreu-Velez; J Graham Smith; Michael S Howard
Journal:  N Am J Med Sci       Date:  2009-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.